Business
Medtronic : Endurant™ stent graft system first and only to receive CE-mark for updated rupture labeling
Medtronic : Endurant™ stent graft system first and only to receive CE-mark for updated rupture
About this update from Medtronic Plc.
Medtronic plc, a global leader in healthcare technology, today announced it has received Conformité Européenne (CE) approval1 for the Medtronic Endurant™ stent graft system to remove the rAAA treatment warning. The CE Mark labeling update follows the U.S. FDA labeling approval received in October 2025 and extends updated Endurant rAAA labeling to support expanded training and educational opportunities in Europe. [...] This is an abstract of the document. To keep reading, click here and get access to the original version.